Public health impact and cost-effectiveness of catch-up 9-valent HPV vaccination of individuals through age 45 years in the United States.
- Resource Type
- Article
- Source
- Human Vaccines & Immunotherapeutics; 2021, Vol. 17 Issue 7, p1943-1951, 9p
- Subject
- Language
- ISSN
- 21645515